Determination of bismuth in pharmaceutical dosage forms by conventional DC polarography.
D000535:Aluminum / Q000032:analysis; D001151:Arsenic / Q000032:analysis; D001205:Ascorbic Acid / Q000032:analysis; D001729:Bismuth / Q000032:analysis*; D003124:Colorimetry; D004338:Drug Combinations; D004655:Emulsions / Q000032:analysis; D005069:Evaluation Studies as Topic; D006018:Glycols / Q000032:analysis; D008722:Methods; D009566:Nitrates / Q000032:analysis; D010087:Oxides / Q000032:analysis; D011048:Polarography; D011208:Powders / Q000032:analysis; D012459:Salicylates / Q000032:analysis; D012964:Sodium / Q000032:analysis; D013535:Suspensions / Q000032:analysis; D013607:Tablets / Q000032:analysis
D004338:Drug Combinations; D004655:Emulsions; D006018:Glycols; D009566:Nitrates; D010087:Oxides; D011208:Powders; D012459:Salicylates; D013535:Suspensions; D013607:Tablets; D012964:Sodium; D000535:Aluminum; D001151:Arsenic; D001205:Ascorbic Acid; D001729:Bismuth